177 related articles for article (PubMed ID: 26748479)
1. Parathyroid Hormone and the Use of Diuretics and Calcium-Channel Blockers: The Multi-Ethnic Study of Atherosclerosis.
Zaheer S; de Boer I; Allison M; Brown JM; Psaty BM; Robinson-Cohen C; Ix JH; Kestenbaum B; Siscovick D; Vaidya A
J Bone Miner Res; 2016 Jun; 31(6):1137-45. PubMed ID: 26748479
[TBL] [Abstract][Full Text] [Related]
2. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women.
Rejnmark L; Vestergaard P; Heickendorff L; Andreasen F; Mosekilde L
Eur J Clin Invest; 2001 Sep; 31(9):764-72. PubMed ID: 11589718
[TBL] [Abstract][Full Text] [Related]
3. Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis.
Brown J; de Boer IH; Robinson-Cohen C; Siscovick DS; Kestenbaum B; Allison M; Vaidya A
J Clin Endocrinol Metab; 2015 Feb; 100(2):490-9. PubMed ID: 25412416
[TBL] [Abstract][Full Text] [Related]
4. Thiazide increases serum calcium in anuric patients: the role of parathyroid hormone.
Vasco RFV; Reis ET; Moyses RMA; Elias RM
Arch Osteoporos; 2017 Dec; 12(1):31. PubMed ID: 28343298
[TBL] [Abstract][Full Text] [Related]
5. Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.
Isakova T; Anderson CA; Leonard MB; Xie D; Gutiérrez OM; Rosen LK; Theurer J; Bellovich K; Steigerwalt SP; Tang I; Anderson AH; Townsend RR; He J; Feldman HI; Wolf M;
Nephrol Dial Transplant; 2011 Apr; 26(4):1258-65. PubMed ID: 21382989
[TBL] [Abstract][Full Text] [Related]
6. Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels.
Sigurdsson G; Franzson L
J Intern Med; 2001 Jul; 250(1):51-6. PubMed ID: 11454142
[TBL] [Abstract][Full Text] [Related]
7. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
Vouri SM; Jiang X; Manini TM; Solberg LM; Pepine C; Malone DC; Winterstein AG
JAMA Netw Open; 2019 Dec; 2(12):e1918425. PubMed ID: 31880802
[TBL] [Abstract][Full Text] [Related]
8. Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover.
Rejnmark L; Vestergaard P; Heickendorff L; Andreasen F; Mosekilde L
J Intern Med; 2005 Feb; 257(2):176-84. PubMed ID: 15656876
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone levels, calcium-channel blockers, and the dyslipidemia of nondiabetic hemodialysis patients.
Zanos S; Mitsopoulos E; Sakellariou G
Ren Fail; 2005; 27(2):163-9. PubMed ID: 15807180
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis.
Bosworth C; Sachs MC; Duprez D; Hoofnagle AN; Ix JH; Jacobs DR; Peralta CA; Siscovick DS; Kestenbaum B; de Boer IH
Clin Endocrinol (Oxf); 2013 Sep; 79(3):429-36. PubMed ID: 23402353
[TBL] [Abstract][Full Text] [Related]
12. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis.
Bansal N; Zelnick L; Robinson-Cohen C; Hoofnagle AN; Ix JH; Lima JA; Shoben AB; Peralta CA; Siscovick DS; Kestenbaum B; de Boer IH
J Am Heart Assoc; 2014 Dec; 3(6):e001278. PubMed ID: 25468653
[TBL] [Abstract][Full Text] [Related]
13. Differences in Health-Related Quality of Life Among Adults with a Potential Dihydropyridine Calcium Channel Blocker-Loop Diuretic Prescribing Cascade.
Morris EJ; Brown JD; Manini TM; Vouri SM
Drugs Aging; 2021 Jul; 38(7):625-632. PubMed ID: 34095980
[TBL] [Abstract][Full Text] [Related]
14. Add-On Antihypertensive Medications to Angiotensin-Aldosterone System Blockers in Diabetes: A Comparative Effectiveness Study.
Schroeder EB; Chonchol M; Shetterly SM; Powers JD; Adams JL; Schmittdiel JA; Nichols GA; O'Connor PJ; Steiner JF
Clin J Am Soc Nephrol; 2018 May; 13(5):727-734. PubMed ID: 29572286
[TBL] [Abstract][Full Text] [Related]
15. Elderly patients with chronic kidney disease have higher risk of hyperparathyroidism.
Elias RM; Moysés RMA
Int Urol Nephrol; 2017 Oct; 49(10):1815-1821. PubMed ID: 28695313
[TBL] [Abstract][Full Text] [Related]
16. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk.
Barzilay JI; Davis BR; Pressel SL; Ghosh A; Puttnam R; Margolis KL; Whelton PK
Curr Cardiol Rep; 2017 Sep; 19(9):76. PubMed ID: 28752275
[TBL] [Abstract][Full Text] [Related]
18. Thiazides and seasonal bone change in healthy postmenopausal women.
Dawson-Hughes B; Harris S
Bone Miner; 1993 Apr; 21(1):41-51. PubMed ID: 8324419
[TBL] [Abstract][Full Text] [Related]
19. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients.
Navarro JF; Mora C; Macia M; Garcia J
Perit Dial Int; 1999; 19(5):455-61. PubMed ID: 11379859
[TBL] [Abstract][Full Text] [Related]
20. Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women.
Rejnmark L; Vestergaard P; Pedersen AR; Heickendorff L; Andreasen F; Mosekilde L
Eur J Clin Invest; 2003 Jan; 33(1):41-50. PubMed ID: 12492451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
